MediWound (MDWD) EBITDA Margin (2014 - 2025)
MediWound's (MDWD) quarterly EBITDA Margin came in at 346.28% in Q4 2025, down 26299.0% year-on-year from N/an in Q4 2024, and down 250.28% quarter-over-quarter from 98.86% in Q3 2025.
MediWound (MDWD) EBITDA Margin (2014 - 2025) Analysis & Trends
MediWound's EBITDA Margin history runs 12 years deep, the most recent figure standing at 346.28% for Q4 2025.
- On a quarterly basis, EBITDA Margin fell 26299.0% year-over-year to 346.28% in Q4 2025; TTM through Dec 2025 was 165.84%, a 7087.0% decrease from a year earlier, with the FY2025 full-year figure at 119.77%, down 4677.0% from the prior year.
- EBITDA Margin fell to 346.28% in Q4 2025 per MDWD's latest filing, from 98.86% in the prior quarter.
- Across five years, EBITDA Margin topped out at 29.47% in Q4 2022 and bottomed at 346.28% in Q4 2025.
- The 5-year median for EBITDA Margin is 87.48% (2023), against an average of 128.4%.
- Across the five-year window, EBITDA Margin jumped 15204 bps in 2021 and sank 26299 bps in 2025, its largest moves.
- Year by year, EBITDA Margin stood at 52.03% in 2021, then jumped by 157 bps to 29.47% in 2022, then sank by 306 bps to 60.64% in 2023, then tumbled by 37 bps to 83.29% in 2024, then slumped by 316 bps to 346.28% in 2025.
- Per Business Quant, the three latest MDWD EBITDA Margin figures stand at 346.28% (Q4 2025), 98.86% (Q3 2025), and 325.88% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | -346.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -346.28% |
| Sep 30, 2025 | -98.86% |
| Jun 30, 2025 | -325.88% |
| Mar 31, 2025 | -101.62% |
| Dec 31, 2024 | -83.29% |
| Sep 30, 2024 | -84.36% |
| Jun 30, 2024 | -287.80% |
| Mar 31, 2024 | -57.49% |
| Dec 31, 2023 | -60.64% |
| Sep 30, 2023 | -54.42% |
| Jun 30, 2023 | -332.26% |
| Mar 31, 2023 | -90.60% |
| Dec 31, 2022 | 29.47% |
| Sep 30, 2022 | -42.48% |
| Jun 30, 2022 | -220.13% |
| Mar 31, 2022 | -59.41% |
| Dec 31, 2021 | -52.03% |
| Sep 30, 2021 | -109.08% |
| Jun 30, 2021 | -114.56% |
| Mar 31, 2021 | -76.29% |